RSS

collaboration

To address the growing gap between how healthcare professionals want to receive information & what can be provided, the world’s largest pharma companies have collaborated to simplify digital engagement. Jan van den Burg, Veeva Systems, tells us more more

Opinion

Science and technology company, Merck, has partnered with Oxford University’s Jenner Institute to develop cost-effective vaccine manufacturing processes, aimed at speeding up vaccine availability. more

News

Ubiquigent and Forma Therapeutics have entered into a multi-year strategic research and development (R&D) collaboration agreement for the design and development of novel deubiquitylase (DUB) enzyme inhibitors. more

News

A strategic partnership has been announced between biopharmaceutical contract services company, KBI, and provider of formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics, ReForm more

News

A collaboration between IONTAS, a company focused on the discovery and optimisation of fully human antibodies, and IGEM Therapeutics, an immunologist-oncology company, for the identification of novel IgE antibodies for cancer targets. more

News

Veeva Systems in collaboration with six contract research organisations (CROs) have introduced a new industry standards group, Align Clinical CRO, that is dedicated to making it easier for sponsors and CROs to work together during clinical trials. more

News

Biotechnology company, Shire, has announced a professional training development collaboration with the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland. more

News

The Pistoia Alliance, a not for profit alliance, has called on the life sciences industry to support the ‘Lab of the Future’ (LoTF) through greater collaboration during its annual EU member conference held in London. more

News

Tonight (28 February), Medicines Discovery Catapult is set to launch its second collaborative project to solve the issue of access to human tissue samples for drug discovery research in the UK. more

News

Global technology and engineering company, Emerson, and Ireland’s National Institute of Bioprocessing Research and Training (NIBRT) have announced a collaboration to help prepare the Irish biopharma workforce for digitisation. more

News

STA Pharmaceutical, a WuXi AppTec company, has signed an oligonucleotide synthesis collaboration agreement with biopharmaceutical company, Regulus Therapeutics, for research and mid-scale non-GMP/cGMP manufacturing. more

News

A collaboration has been initiated between Cullinan Oncology and MAB Discovery that is focused on the development of novel antibody-based therapeutics. more

Technology

Collaborative work on the development of a novel drug delivery system involving a team at Queen’s University Belfast may offer hope to reducing rates of HIV infection in those that are at high risk, it has been announced. more

News

International CDMO of biologics and pharmaceuticals, Cobra Biologics, and CMO specialising in sterile fill finish, Symbiosis Pharmaceutical Services, have been awarded a collaborative grant of £1.9 million from Innovate UK. more

News

The UK’s technology innovation provider for process manufacturing, the CPI, has announced that it is in the final stages of a collaboration project with the University of Edinburgh’s Roslin Institute to transform the manufacture of biologics. more

News

The collaboration between AstraZeneca and TissUse is progressing with the establishment of relevant microphysiological system (MPS) models based on TissUse’s multi-organ-chip technology, the companies announced. more

Technology

A new strategy to tackle the issue of long-term treatment efficacy in cancer patients has been developed by researchers from the Netherlands Cancer Institute in collaboration with international biotechnology company, Genmab. more

News

Nanobiotix, a late clinical-stage nanomedicine company, has started a pre-clinical collaboration with the Providence Cancer Institute to study NBTXR3 — a nanoparticle designed for direct injection into cancerous tumours and activation by radiotherapy more

News

A research collaboration for the development of a specific modified peptide targeting rheumatoid arthritis (RA) has been formed between Pfizer and Imcyse — a biotech company developing specific therapies for the treatment of severe chronic diseases. more

News

Licence terms for the exclusive development and commercialisation rights to certain macrocyclic inhibitors of peptide bond isomerases (cyprolides) have been agreed upon by Cypralis and Gilead Sciences. more

News